The arsenic bacteria story continued to roll on over the last week, but at a slower pace. Many of the big issues have already been covered at length, including the paper itself, the media hype, the implications for journalism, peer review, and so on (see my post-mortem from last week for a timeline; and my original post and first short round-up for background). For this round-up, I’m focusing on some of the fresher perspectives:

Charlie Petit of the Knight Science Journalism Tracker analysed all facets of the story, as he is wont to do. He noted that an editor at Science should have put in more qualifiers into the very paper, particularly the abstract and title, but